Venn Life Sciences Holdings PLC (LSE:VENN) - Share price - Overview

Stock Report

Venn Life Sciences Holdings PLC VENN

Last Price
GBX20.90

Day Change
0.02|0.12%

As of 19/01/2017
08:23:28 GMT | GBX
Minimum 15 Minutes Delay.

Last Close20.88p
Day Range20.90 - 20.90
Mkt Cap12.58Mil
52-Wk Range17.55 - 30.30
Yield %0.00
ISINGB00B9275X97
Volume12,232
P/E51.86
P/S1.02
P/CF-5.43

Share Price

Total Returns 18/01/2017

 Chg (%)  
More ...
Venn Life Sciences Holdings PLC-9.24 
FTSE 100 TR GBP3.41
 
Financials
201320142015
More ...
Income Statement
Turnover1.743.968.47
Operating Profit-1.53-1.44-0.21
Net Profit-1.54-1.47-0.15
Reported EPS-7.69-4.870.03
Balance Sheet
Current Assets1.052.296.92
Non Current Assets0.942.384.32
Total Assets1.994.6711.24
Current Liabilities1.343.193.65
Total Liabilities1.383.263.69
Total Equity0.601.417.55
Cash Flow
Operating Cash Flow-1.54-0.81-1.68
Net Change in Cash-1.960.312.36
Broker Forecasts
Year EndingPre-taxEPSEPSgP/EPEGDPSYld %
More ...
'Broker Forecasts' provides consensus figures based on several brokers' views
20161.432.39492.978.730.02--
20171.802.6912.307.780.63--
Director Dealings
TradedActionNotifierPriceAmountValue
More ...
01/11/2016PurchaseAllan Wood21.73165,00035,855.00
31/10/2016PurchaseAllan Wood21.5065,00013,975.00

Company Profile

Venn Life Sciences Holdings PLC is a Clinical Research Organization. The Company provides consulting and clinical trial services to pharmaceutical, biotechnology and medical device organizations.
 

Sector

Medical Care

Market Position

1463 of 1849 Companies

Index

FTSE AIM All Share

Outlook

(28/09/2016) "...we expect the second half of the year to see the benefits of this acquisition. Overall we continue to see opportunities for further growth"

Next Event 10/05/2017

Next annual report due
Ratios
CompSecMkt
More ...
PER (E)7.7816.7216.17
Div Yld (E)0.001.894.04
PEG (E)0.631.190.92
ROCE-1.5329.77-27.21
Op Mrgn-0.66-19.20-30.25
EPS Grwth12.3033.2425.06
Dividends
PreviousLatest
More ...
Record Datet.b.c.t.b.c.
Ex-Divt.b.c.t.b.c.
Paidt.b.c.t.b.c.
Amnt0.000.00

Broker Sentiment

Strong Buy0
Buy0
Hold0
Sell0
Strong Sell0
  • Strong Sell
  • Strong Buy
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
More ...
Disclaimer
Directors
More ...
ChairmanAllan Wood
Chief Executive OfficerTony Richardson
Chief Financial OfficerJonathan Hartshorn
AJ Bell includes AJ Bell Holdings Limited and its wholly owned subsidiaries. AJ Bell Management Limited and AJ Bell Securities Limited are authorised and regulated by the Financial Conduct Authority. All companies are registered in England and Wales at Trafford House, Chester Road, Manchester M32 0RS. AJ Bell procures the provision of the Morningstar Licensed Tools on an “as is” basis and does not guarantee the performance of or accept liability for the Licensed Tools. To the maximum extent permitted by law, AJ Bell excludes liability for the Licensed Tools, including liability for any failure, interruption, delay or defect in the performance of any Licensed Tool, unless it arises as a direct result of the negligence of AJ Bell.
© Copyright 2017 Morningstar. All rights reserved.